Endovascular treatment of peripheral vascular disease

Authors

Suhail Allaqaband, Aurora Sinai/Aurora St. Luke's Medical Centers, Advocate Aurora HealthFollow
Joaquin Solis, Advocate Aurora HealthFollow
Sepideh Kazemi
Tanvir Bajwa, Aurora Cardiovascular Services, Aurora Sinai/Aurora St. Luke’s Medical Centers, University of Wisconsin School of Medicine and Public HealthFollow

Recommended Citation

Allaqaband S, Solis J, Kazemi S, et al. Endovascular treatment of peripheral vascular disease. Curr Probl Cardiol. 2006 Nov;31(11):711-60.

Abstract

An estimated 10 million people in the U.S. have symptomatic peripheral arterial disease (PAD); 20 to 30 million have asymptomatic PAD. The prevalence of intermittent claudication increases with age, affecting >5% of patients over 70. The incidence of claudication doubles or triples in patients with diabetes. As people grow older, symptoms from peripheral vascular disease increasingly limit daily activity. Until recently, vascular surgical procedures were the only alternative to medical therapy in such patients. Today, advances in minimally invasive percutaneous interventions have made endovascular procedures the primary modality for revascularization in most patients. Compared with open surgical procedures, endovascular interventions offer comparable or superior long-term rates of success with very low rates for morbidity and mortality. Furthermore, most of these interventions are performed on an outpatient basis, reducing hospital stays considerably. In this monograph we discuss current endovascular interventions for treating occlusive PAD, aneurysmal arterial disease, and increasingly common venous occlusive diseases.

Document Type

Article

PubMed ID

17052478